Loading
Latest filing published 18 Apr 2023 for Timber Pharmaceuticals, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gianluca Pirozzi, listed as board member, appears in our data through filings on Timber Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 15 April 2022 and the latest from 15 April 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 18 April 2023, the filings show a share grant in Timber Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations